Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1153 Preclinical activity of C-C chemokine receptor 2 (CCR2)-targeted immune stimulating antibody conjugate (ISAC), motivating clinical testing of TAK-500
Compose a Response to This Article
Other responses
No responses have been published for this article.